Route selection & development

RML Pharma Consulting has expertise in synthetic chemistry and is experienced in developing scaleable and sustainable synthetic routes and processes for GMP manufacture of API.
 Evaluate your current synthetic route in terms of long term viability.
Provide a projected cost of goods for the API to identify potential issues which may preclude the development of your asset for the targeted therapeutic area.
Initiate and coordinate a program of process development activity at contract to support the next manufacturing campaign.
We can propose and exemplify alternative synthetic routes to your API, addressing specific issues that you may have identified with the current route (eg cost, availability of starting materials).

In order to reduce cash burn, we can also carry out a minimal development approach which targets only the development activities needed to get you to your next milestone.